Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.

Inclusion Criteria: * 18 years or older at the time of enrollment in the study. * Diagnosed with type 2 diabetes according to the Guidelines for the diagnosis of type 2 diabetes of the Ministry of Health (2011). * Fasting blood glucose ≤ 10.0 mmol/L. * No previous treatment with metformin or other antidiabetic drugs. * Ability and willingness to provide written informed consent and comply with the protocol's requirements. * Subject who, in the judgment of the Investigator, is likely to be compliant or cooperative during the study. Exclusion Criteria: * The patient has been diagnosed with diabetes and has been previously treated with metformin or other antidiabetic agents. * Patients with indications for insulin therapy or combination therapy of two or more drugs according to the guidelines for diagnosis and treatment of type 2 diabetes of the Ministry of Health. * Pregnancy or lactation. * Patients with contraindications to Metformin include severe liver and/or kidney disease, congestive heart failure, cardiovascular collapse, acute myocardial infarction, severe infection, and sepsis. * Patients with conditions and circumstances that, in the investigator's opinion, are difficult to ensure adherence to study protocol.